Robert Strauss

3.1k total citations · 1 hit paper
38 papers, 2.4k citations indexed

About

Robert Strauss is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert Strauss has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Genetics. Recurrent topics in Robert Strauss's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Robert Strauss is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Robert Strauss collaborates with scholars based in United States, Denmark and Czechia. Robert Strauss's co-authors include André Lieber, Jiří Bártek, Thomas Boyer, Pavel Moudrý, Apolinar Maya‐Mendoza, Joanna Maria Merchut‐Maya, Myunghee Lee, Sebastian Tuve, Zong-Yi Li and Ines Beyer and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

Robert Strauss

38 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High speed of fork progression induces DNA replication stress and genomic instability

2018 356 citations Pavel Moudrý, Joanna Maria Merchut‐Maya et al. profile →

Peers

Countries citing papers authored by Robert Strauss

Since Specialization

Citations

This map shows the geographic impact of Robert Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Strauss more than expected).

Fields of papers citing papers by Robert Strauss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Strauss. The network helps show where Robert Strauss may publish in the future.

Co-authorship network of co-authors of Robert Strauss

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Strauss. A scholar is included among the top collaborators of Robert Strauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Strauss. Robert Strauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repurposing Asparaginase Therapy to Target Cisplatin‐Resistant Cancer Cells 2025 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), Robert Strauss, Jiří Bártek, (unknown), Sean G. Rudd	1
2	Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis 2023 ·Oncogene ·(unknown), (unknown), (unknown), Jinrong Huang, (unknown), (unknown), (unknown), Zsófia Sztupinszki, Robert Strauss, Mesut Bilgin, Kenji Maeda, Bin Liu, Yonglun Luo, Marja Jäättelä, Tuula Kallunki	11
3	SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells 2020 ·Nature Communications ·Elisabeth Anne Adanma Obara, Diana Aguilar‐Morante, Rikke Rasmussen, Alex Frías, Kristoffer Vitting‐Seerup, Yi Chieh Lim, (unknown), (unknown), Lina Vardouli, Kamilla E. Jensen, Jane Skjøth‐Rasmussen, Jannick Brennum, Lucie Tučková, Robert Strauss, Christoffel Dinant, Jiří Bártek, Petra Hamerlik	17
4	Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay 2019 ·JNCI Journal of the National Cancer Institute ·Freija Verdoodt, Christian Dehlendorff, Marja Jäättelä, Robert Strauss, Anton Pottegård, Jesper Hallas, Søren Friis, Susanne K. Kjær	28
5	Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAFE600 inhibition in melanoma cells 2019 ·Journal of Controlled Release ·Arnaldur Hall, Scott Maynard, Linping Wu, Joanna Maria Merchut‐Maya, Robert Strauss, S. Moein Moghimi, Jiří Bártek	4
6	Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress 2016 ·Oncogene ·(unknown), Martin Mistrík, Pavel Moudrý, Ján Gurský, (unknown), Robert Strauss, Zdeněk Škrott, Radek Vrtěl, Jiřina Bártková, Juraj Kramara, Jiří Bártek	44
7	Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells 2016 ·Cancer Biology & Therapy ·Kamola Saydaminova, Robert Strauss, Min Xie, Jiří Bártek, (unknown), Ruan van Rensburg, Charles W. Drescher, Anja Ehrhardt, Sheng Ding, André Lieber	6
8	Strategies to Increase Drug Penetration in Solid Tumors 2013 ·Frontiers in Oncology ·(unknown), Robert Strauss, Maximilian Richter, Chae‐Ok Yun, André Lieber	143
9	Regulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer 2012 ·Molecular Therapy ·Robert Strauss, Petra Hamerlik, André Lieber, Jiří Bártek	23
10	Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer 2011 ·Cancer Research ·Ines Beyer, Ruan van Rensburg, Robert Strauss, Zongyi Li, Hongjie Wang, Jonas Persson, Roma Yumul, Qinghua Feng, (unknown), Jiří Bártek, Pascal Fender, André Lieber	69
11	Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14 2010 ·Nature Medicine ·Hongjie Wang, Zong-Yi Li, Ying Liu, Jonas Persson, Ines Beyer, Thomas Möller, (unknown), (unknown), Robert Strauss, Xiao‐Bing Zhang, James K. Wahl, Nicole Urban, Charles W. Drescher, Akseli Hemminki, Pascal Fender, André Lieber	328
12	Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses 2009 ·Cancer Research ·Robert Strauss, Pavel Sova, Ying Liu, (unknown), Sebastian Tuve, David K. Pritchard, Paul T. Brinkkoetter, T. Möller, Oliver Wildner, Sari Pesonen, Akseli Hemminki, Nicole Urban, Charles W. Drescher, André Lieber	57
13	In situ adenovirus vaccination engages T effector cells against cancer 2009 ·Vaccine ·Sebastian Tuve, Ying Liu, Khajornsak Tragoolpua, Jeffrey Jacobs, Roma Yumul, Zong-Yi Li, Robert Strauss, K E Hellström, Mary L. Disis, Steve R. Roffler, André Lieber	37
14	Combination of Tumor Site–Located CTL-Associated Antigen-4 Blockade and Systemic Regulatory T-Cell Depletion Induces Tumor-Destructive Immune Responses 2007 ·Cancer Research ·Sebastian Tuve, Bing-Mae Chen, Ying Liu, Tian‐Lu Cheng, Papa Souleymane Touré, Papa Salif Sow, Qinghua Feng, Nancy Kiviat, Robert Strauss, Shaoheng Ni, Zong-Yi Li, Steve R. Roffler, André Lieber	75
15	Comparison of Adenoviruses From Species B, C, E, and F After Intravenous Delivery 2007 ·Molecular Therapy ·Daniel Stone, Ying Liu, Zong-Yi Li, Sebastian Tuve, Robert Strauss, André Lieber	51
16	Baculovirus-based Vaccination Vectors Allow for Efficient Induction of Immune Responses Against Plasmodium falciparum Circumsporozoite Protein 2006 ·Molecular Therapy ·Robert Strauss, Andreas Hüser, Shaoheng Ni, Sebastian Tuve, Nancy B. Kiviat, Papa Salif Sow, Christian Hofmann, André Lieber	104
17	Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting 2006 ·Cancer Gene Therapy ·Shaoheng Ni, Anuj Gaggar, (unknown), (unknown), (unknown), Robert Strauss, Pavel Sova, Janice Morihara, Qinghua Feng, (unknown), Papa Souleymane Touré, Papa Salif Sow, André Lieber	45
18	Galanin Immunoreactivity in Paragangliomas but Not in Carcinoid Tumors 2003 ·Applied immunohistochemistry & molecular morphology ·Talaat S. Tadros, Robert Strauss, Cynthia Cohen, Anthony A. Gal	10
19	Hepatic Hydrothorax 1997 ·Seminars in Liver Disease ·Robert Strauss, Thomas Boyer	95
20	Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy 1990 ·The American Journal of Medicine ·Robert Strauss, Timothy C. Wang, Peter B. Kelsey, Carolyn C. Compton, (unknown), (unknown), Julie Parsonnet, Martin J. Blaser	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact